Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Gaugene
company
About
Gaugene provides hematology testing instruments, reagents, and services for IVD users.
Details
- Last Funding Type
- Series B
- Last Funding Money Raised
- ¥100M
- Industries
- Biotechnology,Health Diagnostics
- Founded date
- Jan 1, 2017
- Operating Status
- Active
Gaugene provides hematology testing instruments, reagents, and services for IVD users. Gaugene is a high-tech enterprise co-sponsored by core technology management backbones of well-known domestic IVD companies with rich management experience who master the industry’s top technologies.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
¥100M
Gaugene has raised a total of
¥100M
in funding over 2 rounds. Their latest funding was raised on
Jul 15, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 15, 2022 | Series B | ¥100M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Gaugene is funded by 2 investors.
Anbiping
and Huihe Capital
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Anbiping
|
— | Series B |
|
|
— | Series B |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
